Clinical trials
Phase 1 Neuromyelitis Optica trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 8 |
| Not yet recruiting | 5 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tongji Hospital | 3 |
| Chinese PLA General Hospital | 2 |
| Johns Hopkins University | 2 |
| Tianjin Huanhu Hospital | 2 |
| Abide Therapeutics | 1 |
| Bio-Thera Solutions | 1 |
| Guangzhou Lupeng Pharmaceutical Company LTD. | 1 |
| Harbour BioMed (Guangzhou) Co. Ltd. | 1 |
| Huashan Hospital | 1 |
| Michael Levy | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromyelitis Optica | 27 |
| Multiple Sclerosis | 13 |
| Myasthenia Gravis | 9 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 5 |
| Autoimmune Diseases of the Nervous System | 4 |
| Lupus Erythematosus, Systemic | 3 |
| Myelitis, Transverse | 3 |
| Myositis | 3 |
| Scleroderma, Systemic | 3 |
| Optic Neuritis | 2 |
Trials
Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.